
### [DOID:3996](http://purl.obolibrary.org/obo/DOID_3996)
**Label:** urinary system cancer

**Subclasses:** [DOID:2154](http://purl.obolibrary.org/obo/DOID_2154) (nephroblastoma), [DOID:11054](http://purl.obolibrary.org/obo/DOID_11054) (urinary bladder cancer), [DOID:4450](http://purl.obolibrary.org/obo/DOID_4450) (renal cell carcinoma), [DOID:11819](http://purl.obolibrary.org/obo/DOID_11819) (ureter cancer), 

**Corr. equiv. classes:** [OMIM:109800](http://purl.obolibrary.org/obo/OMIM_109800), [OMIM:191600](http://purl.obolibrary.org/obo/OMIM_191600), [OMIM:194070](http://purl.obolibrary.org/obo/OMIM_194070), [OMIM:300854](http://purl.obolibrary.org/obo/OMIM_300854), 

**Class expressions from DL-Learner:**

- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0010786](http://purl.obolibrary.org/obo/HP_0010786) (Urinary tract neoplasm) 90.82%
- [HP:0010786](http://purl.obolibrary.org/obo/HP_0010786) (Urinary tract neoplasm) 85.36%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0010786](http://purl.obolibrary.org/obo/HP_0010786) (Urinary tract neoplasm) 75.00%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0009726](http://purl.obolibrary.org/obo/HP_0009726) (Renal neoplasm) 75.00%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0010786](http://purl.obolibrary.org/obo/HP_0010786) (Urinary tract neoplasm) and [HP:0010935](http://purl.obolibrary.org/obo/HP_0010935) (Abnormality of the upper urinary tract) 75.00%
- [HP:0000079](http://purl.obolibrary.org/obo/HP_0000079) (Abnormality of the urinary system) and [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0010786](http://purl.obolibrary.org/obo/HP_0010786) (Urinary tract neoplasm) 75.00%
- [HP:0000077](http://purl.obolibrary.org/obo/HP_0000077) (Abnormality of the kidney) and [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0010786](http://purl.obolibrary.org/obo/HP_0010786) (Urinary tract neoplasm) 75.00%
- [HP:0100516](http://purl.obolibrary.org/obo/HP_0100516) (Neoplasm of the ureter) 62.50%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0011794](http://purl.obolibrary.org/obo/HP_0011794) (Embryonal renal neoplasm) 62.50%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0005584](http://purl.obolibrary.org/obo/HP_0005584) (Renal cell carcinoma) 62.50%
- [HP:0001428](http://purl.obolibrary.org/obo/HP_0001428) (Somatic mutation) and [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) 62.50%
- [HP:0001425](http://purl.obolibrary.org/obo/HP_0001425) (Heterogeneous) and [HP:0011794](http://purl.obolibrary.org/obo/HP_0011794) (Embryonal renal neoplasm) 62.50%
- [HP:0001425](http://purl.obolibrary.org/obo/HP_0001425) (Heterogeneous) and [HP:0010786](http://purl.obolibrary.org/obo/HP_0010786) (Urinary tract neoplasm) 62.50%
- [HP:0001425](http://purl.obolibrary.org/obo/HP_0001425) (Heterogeneous) and [HP:0009726](http://purl.obolibrary.org/obo/HP_0009726) (Renal neoplasm) 62.50%
- [HP:0001425](http://purl.obolibrary.org/obo/HP_0001425) (Heterogeneous) and [HP:0002667](http://purl.obolibrary.org/obo/HP_0002667) (Nephroblastoma) 62.50%


